ARDS (Aridis Pharmaceuticals) Institutional Ownership: 1.00% (As of Jul. 05, 2026)


ARDS Aridis Pharmaceuticals Inc ARDS
12 GF Score
Price $0.00
View Full Analysis

What is Aridis Pharmaceuticals Institutional Ownership?

Aridis Pharmaceuticals ARDS -99.00% 12 Institutional Ownership is 1.00% as of Jul. 05, 2026. GuruFocus rates ARDS with a GF Score™ of 12/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aridis Pharmaceuticals's institutional ownership is 1.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aridis Pharmaceuticals's Insider Ownership is 5.14%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aridis Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 85.17%.

Aridis Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Aridis Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aridis Pharmaceuticals Institutional Ownership Chart

Aridis Pharmaceuticals Historical Data

The historical data trend for Aridis Pharmaceuticals can be seen below:

2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31
Institutional Ownership 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.00 1.00
ARDS
12GF Score
Aridis Pharmaceuticals Inc ARDS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aridis Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.00% mean?
Aridis Pharmaceuticals (ARDS) has a Institutional Ownership of 1.00% as of Jul. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aridis Pharmaceuticals and its competitors.
Is Aridis Pharmaceuticals' Institutional Ownership too high?
Aridis Pharmaceuticals' current Institutional Ownership is 1.00%. Overall, Aridis Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Aridis Pharmaceuticals' Institutional Ownership compare to ARTL and REVB?
Aridis Pharmaceuticals' Institutional Ownership of 1.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aridis Pharmaceuticals and its competitors. Aridis Pharmaceuticals's current Institutional Ownership is 1.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aridis Pharmaceuticals stock overvalued right now?
Aridis Pharmaceuticals (ARDS) has a current Institutional Ownership of 1.00%. The current Institutional Ownership is 1.00%. Aridis Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Aridis Pharmaceuticals (ARDS), the current Institutional Ownership is 1.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aridis Pharmaceuticals Business Description

Address 983 University Avenue, Building B, Los Gatos, CA, USA, 95032
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
12GF Score

Get the complete analysis for ARDS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price